Set as Homepage - Bookmark This Page   
You are here:Home >Tech & Dev >Waters... noitazilaicremmoC dna tnempole Content

Waters... noitazilaicremmoC dna tnempole

Source: AstarEditor: Tech & DevDate: 2025-05-21 19:23:24
Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists

0.27s , 6839.4296875 kb

Copyright © 2025 Powered by Waters... noitazilaicremmoC dna tnempole,Astar  

sitemap

Top